maritide weight loss news - Search News

Amgen says obesity drug caused up to 20% weight loss

The New York Times · 1d

New Drug Causes 20 Percent Weight Loss in Early Amgen Results

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year. The drug, MariTide, is given by injection once a month, compared with once a week for other obesity drugs like Wegovy and Zepbound that are already on the market.

biopharma-reporter · 49m

Amgen announces positive Phase 2 results for its GLP-1-GIP weight loss drug

MariTide is being studied for the treatment of obesity and Type 2 diabetes and demonstrated weight loss at 52 weeks.

CNBC on MSN · 2d

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other experimental treatments.

Amgen’s MariTide achieves 20% weight loss, but Wall Street remains unimpressed

Amgen released the long-awaited results from its study of weight loss injection MariTide and the results — while ...

2d

AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDY

Amgen (NASDAQ:AMGN) today announced positive data at 52 weeks in a double-blind, dose-ranging Phase 2 study with MariTide ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results